Intraperitoneal 5-Fluorouracil treatment of cancer - clinical and experimental studies

作者: Mikael Öman

DOI:

关键词:

摘要: Background:Pancreas cancer is a most aggressive malignancy. More than 80% of patients diagnosed with pancreas cancer, exhibit such advanced disease, that curative surgery impossible. Systemic ch ...

参考文章(162)
Ulrich Schäfer, Eckehard Horst, Oliver Micke, Norman Willich, Rene Kurowski, Frank Bruns, CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy Anticancer Research. ,vol. 23, pp. 835- 840 ,(2003)
P. Cheverton, H. Friess, C. Andras, T. Salek, C. Geddes, G. Bodoky, J. Valle, Y. Humblet, Phase III results of exatecan (DX-8951f) versus gemcitabine (Gem) in chemotherapy-naïve patients with advanced pancreatic cancer (APC) Journal of Clinical Oncology. ,vol. 22, pp. 4005- 4005 ,(2004) , 10.1200/JCO.2004.22.90140.4005
D. Barana, P. Pederzoli, Cristina Oliani, G. Cavallini, C. Bassi, G. L. Cetto, M. Falconi, M. Padovani, P. Manno, Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study. Anticancer Research. ,vol. 24, pp. 2107- 2112 ,(2004)
Hakes T, Barakat R, Reichman B, Almadrones L, Jones W, Lewis Jl, Curtin J, Rowinsky E, Markman M, Rubin S, Intraperitoneal administration of Taxol in the management of ovarian cancer. Journal of The National Cancer Institute Monographs. pp. 103- 106 ,(1993)
Mikael Öman, Per-Jonas Blind, Lars-Olof Hafström, Peter Naredi, Jukka Tölli, 133Xe clearance estimates the effect of vasopressin on peritoneal blood flow in rats. Hepato-gastroenterology. ,vol. 51, pp. 1037- 1041 ,(2004)
Paola Capelli, S. Hirohashi, Aldo Scarpa, Giuseppe Zamboni, Calogero Iacono, T. Oda, K. Mukai, Pancreatic adenocarcinomas frequently show p53 gene mutations American Journal of Pathology. ,vol. 142, pp. 1534- 1543 ,(1993)
Not Available Not Available, Not Available Not Available, Not Available Not Available, Not Available Not Available, Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. Cancer Chemotherapy and Pharmacology. ,vol. 47, pp. 269- 276 ,(2001) , 10.1007/S002800000214
DeVita Vt, Dedrick Rl, Myers Ce, Bungay Pm, Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer Cancer treatment reports. ,vol. 62, pp. 1- 11 ,(1978)